LXEO(Lexeo Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-17 | Tamayo Louis Edward | Chief Financial Officer | 公开市场卖出 | 1,007 | $3.26 |
| 2026-11-17 | Otero Jose Manuel | Chief Operating Officer | 公开市场卖出 | 1,285 | $3.26 |
| 2026-11-17 | Townsend Richard Nolan | Chief Executive Officer | 公开市场卖出 | 3,295 | $3.26 |
| 2026-08-18 | Tamayo Louis Edward | Chief Financial Officer | 公开市场卖出 | 4,117 | $4.91 |
| 2026-08-18 | Otero Jose Manuel | Chief Operating Officer | 公开市场卖出 | 1,304 | $4.96 |
| 2026-08-18 | Townsend Richard Nolan | Chief Executive Officer | 公开市场卖出 | 3,345 | $4.95 |
| 2026-07-01 | Bhalla Narinder Pal | Chief Medical Officer | 公开市场卖出 | 22,306 | $4.42 |
| 2026-07-01 | Tamayo Louis Edward | Chief Financial Officer | 公开市场卖出 | 4,641 | $4.49 |
| 2026-07-01 | Otero Jose Manuel | Chief Operating Officer | 公开市场卖出 | 4,666 | $4.48 |
| 2026-07-01 | Townsend Richard Nolan | Chief Executive Officer | 公开市场卖出 | 25,947 | $4.48 |
| 2026-05-18 | Otero Jose Manuel | Chief Operating Officer | 公开市场卖出 | 1,302 | $5.07 |
| 2026-05-18 | Townsend Richard Nolan | Chief Executive Officer | 公开市场卖出 | 3,342 | $5.06 |
| 2026-04-06 | Townsend Richard Nolan | Chief Executive Officer | 公开市场卖出 | 55,000 | $5.69 |
| 2026-02-18 | Otero Jose Manuel | Chief Operating Officer | 公开市场卖出 | 3,016 | $6.40 |
| 2026-02-18 | Townsend Richard Nolan | Chief Executive Officer | 公开市场卖出 | 10,173 | $6.38 |
| 2025-11-18 | Otero Jose Manuel | Chief Operating Officer | 公开市场卖出 | 721 | $9.27 |
| 2025-11-18 | See Tai Sandi | Chief Development Officer | 公开市场卖出 | 386 | $9.27 |
| 2025-11-18 | Townsend Richard Nolan | Chief Executive Officer | 公开市场卖出 | 1,127 | $9.27 |
| 2025-11-18 | Robertson Jenny | Chief Legal Officer | 公开市场卖出 | 549 | $9.27 |
| 2025-11-18 | Adler Eric | Chief Medical Officer | 公开市场卖出 | 615 | $9.27 |